In fact, neurological abnormalities are far more prevalent in ADA-SCID than other forms of immunodeficiency, indicating that the underlying metabolic disruption caused by ADA deficiency affects the CNS, both in function and development. This evidence concerns the gene ADA and immune system disorder.